Renaissance Technologies - UNICYCIVE THERAPEUTICS INC ownership

UNICYCIVE THERAPEUTICS INC's ticker is and the CUSIP is 90466Y103. A total of 10 filers reported holding UNICYCIVE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of UNICYCIVE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$8,000
-11.1%
12,900
+17.3%
0.00%
Q2 2022$9,00011,0000.00%
Other shareholders
UNICYCIVE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Nantahala Capital Management 700,000$1,981,0000.06%
Board of Trustees of The Leland Stanford Junior University 247,583$700,0000.05%
TANDEM CAPITAL MANAGEMENT CORP /ADV 15,500$44,0000.03%
SANDERS MORRIS HARRIS LLC 20,000$57,0000.01%
Frontier Wealth Management LLC 18,838$53,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 26,109$73,0000.00%
BlackRock Inc. 11,443$33,0000.00%
UBS Group AG 621$2,0000.00%
TWO SIGMA INVESTMENTS, LP 25,551$72,0000.00%
WELLS FARGO & COMPANY/MN 32$00.00%
View complete list of UNICYCIVE THERAPEUTICS INC shareholders